H. H. Haptu

Lynn University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Ranjani K. Paradise

Tufts University

Andrew Tibbs

Massachusetts Department of Public Health

Jennifer Cochran

Massachusetts Department of Public Health

Andrew Hill

Centers for Disease Control and Prevention

VS Green

National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention

David D. McManus

University of Massachusetts Chan Medical School

Dylan B. Tierney

Brigham and Women's Hospital

Suzanne M. Marks

Centers for Disease Control and Prevention

D. M. Sanderson

Massachusetts Department of Public Health

John Bernardo

Vrije Universiteit Amsterdam

Cooperative Institutions

Centers for Disease Control and Prevention

National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention

Massachusetts Department of Public Health

Centers for Disease Control and Prevention

National Center for Immunization and Respiratory Diseases

Boston University

Institute for Community Health

National Center for Emerging and Zoonotic Infectious Diseases

Emory University

Massachusetts General Hospital

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Scaling Up Latent Tuberculosis Infection Testing and Treatment for Non-US Born Patients in a Federally Qualified Community Health Center

Journal of Immigrant and Minority Health (2023)

Jennifer Cochran Andrew Tibbs H. H. Haptu Ranjani K. Paradise John Bernardo

Abstract In the United States (US), tuberculosis elimination strategies include scaling up latent tuberculosis infection (LTBI) diagnosis and treatment for persons at risk of progression to tuberculosis disease. The Massachusetts Department of Public Health partnered with Lynn Community Health Center to provide care to patients with LTBI who were born outside the US. The electronic health record was modified to facilitate collection of data elements for public health assessment of the LTBI care cascade. Among health center patients born outside the US, testing for tuberculosis infection increased by over 190%. From October 1, 2016 to March 21, 2019, 8827 patients were screened and 1368 (15.5%) were diagnosed with LTBI. Using the electronic health record, we documented treatment completion for 645/1368 (47.1%) patients. The greatest drop-offs occurred between testing for TB infection and clinical evaluation after a positive test (24.3%) and between the recommendation for LTBI treatment and completion of a treatment course (22.8%). Tuberculosis care delivery was embedded in the primary care medical home, bringing patient-centered care to those at high risk for loss to follow up. The partnership between public health and the community health center promoted quality improvement.

Community health center

Medical record

Community Health

10.1007/s10903-023-01514-0

Cite

Citations (0)

Cost-effectiveness of expanded latent TB infection testing and treatment: Lynn City, Massachusetts, USA

The International Journal of Tuberculosis and Lung Disease (2024)

Garrett R. Beeler Asay Rachel Yelk Woodruff D. M. Sanderson C.F. Fisher Suzanne M. Marks

BACKGROUND: Between October 2016 and March 2019, Lynn Community Health Center in Massachusetts implemented a targeted latent TB infection testing and treatment (TTT) program, increasing testing from a baseline of 1,200 patients tested to an average of 3,531 patients tested, or 9% of the population per year. METHODS: We compared pre-implementation TTT, represented by the first two quarters of implementation data, to TTT, represented by 12 quarters of data. Time, diagnostic, and laboratory resources were estimated using micro-costing. Other cost and testing data were obtained from the electronic health record, pharmaceutical claims, and published reimbursement rates. A Markov cohort model estimated future health outcomes and cost-effectiveness from a societal perspective in 2020 US dollars. Monte Carlo simulation generated 95% uncertainty intervals. RESULTS: The TTT program exhibited extended dominance over baseline pre-intervention testing and had an incremental cost-effectiveness ratio (ICER) of US$52,603 (US$22,008â–“US$95,360). When compared to baseline pre-TTT testing, the TTT program averted an estimated additional 7.12 TB cases, 3.49 hospitalizations, and 0.16 deaths per lifetime cohort each year. CONCLUSIONS: TTT was more cost-effective than baseline pre-implementation testing. Lynn Community Health Centerâ–™s experience can help inform other clinics considering expanding latent TB infection testing.

Reimbursement

Baseline (sea)

10.5588/ijtld.22.0654

Cite

Citations (2)